Compound Detail
CHEMBL53
APOMORPHINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL53 |
| Name | APOMORPHINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | VMWNQDUVQKEIOC-CYBMUJFWSA-N |
| Therapeutic | ✓ Yes |
38
Targets
211
Activities
4
Assay Types
5
PK Parameters
20
Publications
6
Known Names
5
Indications
Molecular Properties
267.3
MW (Da)
2.85
ALogP
3
HBA
2
HBD
43.7
PSA (Ų)
0.72
QED
0
Ro5 Violations
0
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2001 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Indications
Erectile Dysfunction Parkinson Disease Alcoholism Brain Injuries Hallucinations
ATC Classification
G04BE07
apomorphine
Level 1: GENITO URINARY SYSTEM AND SEX HORMONES
Level 2: UROLOGICALS
N04BC07
apomorphine
Level 1: NERVOUS SYSTEM
Level 2: ANTI-PARKINSON DRUGS
Activity Summary
Ki 83 meas. best 9.21
IC50 80 meas. best 9.0
EC50 40 meas. best 9.4
Kd 8 meas. best 9.18
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| D(2) dopamine receptor CHEMBL339 | EC50 | 9.4 | 8.468 | 0.4 | 5 |
| D(2) dopamine receptor CHEMBL217 | Ki | 9.21 | 7.4735 | 0.6 | 20 |
| D(2) dopamine receptor CHEMBL217 | Kd | 9.18 | 7.9 | 0.7 | 3 |
| D(2) dopamine receptor CHEMBL339 | IC50 | 9.0 | 7.7174 | 1.0 | 19 |
| Dopamine receptor CHEMBL2096970 | IC50 | 9.0 | 7.2569 | 1.0 | 13 |
| Dopamine receptor CHEMBL2093868 | IC50 | 9.0 | 7.988 | 1.0 | 10 |
| Unchecked CHEMBL612545 | EC50 | 8.82 | 8.82 | 1.5 | 1 |
| D(4) dopamine receptor CHEMBL3361 | EC50 | 8.82 | 8.4467 | 1.5 | 3 |
| D(2) dopamine receptor CHEMBL217 | EC50 | 8.8 | 8.1708 | 1.6 | 13 |
| Dopamine receptors; D1 & D2 CHEMBL2096910 | IC50 | 8.77 | 8.77 | 1.7 | 1 |
| D(2) dopamine receptor CHEMBL339 | Ki | 8.74 | 7.8985 | 1.8 | 13 |
| D(3) dopamine receptor CHEMBL234 | Ki | 8.59 | 8.01 | 2.6 | 5 |
| Dopamine receptor CHEMBL2096970 | Ki | 8.43 | 8.43 | 3.7 | 1 |
| D(1A) dopamine receptor CHEMBL2056 | EC50 | 8.42 | 7.3783 | 3.8 | 6 |
| D(2) dopamine receptor CHEMBL217 | IC50 | 8.38 | 7.655 | 4.2 | 2 |
| D(4) dopamine receptor CHEMBL219 | EC50 | 8.37 | 8.37 | 4.3 | 2 |
| D(4) dopamine receptor CHEMBL219 | Ki | 8.36 | 8.205 | 4.4 | 2 |
| D(1A) dopamine receptor CHEMBL2056 | Ki | 8.34 | 6.7322 | 4.6 | 9 |
| D(3) dopamine receptor CHEMBL234 | EC50 | 8.15 | 8.15 | 7.0 | 1 |
| Rattus norvegicus CHEMBL376 | Ki | 7.98 | 7.98 | 10.5 | 1 |
| D(1B) dopamine receptor CHEMBL1850 | Ki | 7.82 | 7.27 | 15.0 | 2 |
| Rattus norvegicus CHEMBL376 | IC50 | 7.65 | 6.9233 | 22.6 | 3 |
| Dopamine receptor D2 and D3 CHEMBL2111342 | IC50 | 7.61 | 7.385 | 24.3 | 2 |
| Dopamine receptor CHEMBL2096905 | IC50 | 7.6 | 7.6 | 25.0 | 1 |
| D(3) dopamine receptor CHEMBL3138 | IC50 | 7.57 | 7.55 | 27.2 | 2 |
| Alpha-2C adrenergic receptor CHEMBL1916 | Ki | 7.44 | 7.44 | 36.3 | 1 |
| Oryctolagus cuniculus CHEMBL374 | EC50 | 7.36 | 7.36 | 44.0 | 1 |
| D(1A) dopamine receptor CHEMBL265 | Ki | 7.28 | 6.5856 | 53.0 | 9 |
| Adrenergic receptor alpha-2 CHEMBL2093864 | IC50 | 7.2 | 6.6467 | 63.0 | 3 |
| Alpha-1D adrenergic receptor CHEMBL223 | Ki | 7.19 | 7.19 | 64.6 | 1 |
| Alpha-2B adrenergic receptor CHEMBL1942 | Ki | 7.18 | 7.18 | 66.1 | 1 |
| D(1A) dopamine receptor CHEMBL3071 | Ki | 7.0 | 7.0 | 101.0 | 1 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | Ki | 6.99 | 6.99 | 102.0 | 1 |
| 5-hydroxytryptamine receptor 1A CHEMBL214 | Ki | 6.93 | 6.558 | 117.0 | 5 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | Ki | 6.92 | 6.92 | 120.0 | 2 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | Ki | 6.88 | 6.88 | 132.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | EC50 | 6.78 | 5.8614 | 168.0 | 7 |
| 5-hydroxytryptamine receptor 7 CHEMBL3223 | Ki | 6.73 | 6.73 | 188.0 | 3 |
| E3 ubiquitin-protein ligase Mdm2 CHEMBL5023 | IC50 | 6.71 | 6.69 | 195.0 | 2 |
| D(2) dopamine receptor CHEMBL339 | Kd | 6.7 | 6.16 | 200.0 | 4 |
| D(2) dopamine receptor CHEMBL3998 | Ki | 6.7 | 6.7 | 200.0 | 1 |
| D(1A) dopamine receptor CHEMBL265 | IC50 | 6.62 | 6.3233 | 238.0 | 9 |
| 5-hydroxytryptamine receptor 1A CHEMBL273 | Ki | 6.53 | 6.53 | 296.0 | 3 |
| Opioid receptor CHEMBL2094129 | IC50 | 6.52 | 6.52 | 302.0 | 1 |
| Unchecked CHEMBL612545 | Ki | 6.27 | 6.27 | 532.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 6.22 | 5.515 | 600.0 | 2 |
| D(1A) dopamine receptor CHEMBL2056 | Kd | 6.17 | 6.17 | 680.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 5.62 | 5.62 | 2398.8 | 1 |
| Zinc finger protein mex-5 CHEMBL1293319 | EC50 | 5.48 | 5.48 | 3293.0 | 1 |
| Aspartyl aminopeptidase CHEMBL1293263 | IC50 | 5.43 | 5.43 | 3669.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 40.0 | mL.min-1.kg-1 | Homo sapiens |
| Fu | 0.057 | - | Homo sapiens |
| MRT | 0.67 | hr | Homo sapiens |
| T1/2 | 0.68 | hr | Homo sapiens |
| T1/2 | 1.0 | hr | Not specified |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine